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Summary.-The growth pattern and morphology of two transplantable acute
leukaemias which arose spontaneously in pure line rats are described. They differ
morphologically and on the basis of their behaviour in vivo, such as infiltration of
lymphoid organs and presence in thoracic duct lymph, the leukaemia syngeneic to
the August strain (referred to as the SAL) appears to be of myeloid type whereas the
leukaemia syngeneic to the Hooded strain (referred to as the HRL) resembles acute
lymphoblastic leukaemia. The HRL cells, but not the SAL cells, are lysed by murine
anti-O serum plus complement. These two transplantable acute leukaemias appear
to be useful animal counterparts to the human acute leukaemias and may be valuable
models for studies on chemotherapy and immunotherapy.
SPONTANEOUSLY occurring leukaemias
are uncommon in rats (Moloney, Boschetti
and King, 1969; Moloney, 1974) and
carcinogens which readily produce
leukaemias in mice are less effective in
rats (Moloney, Boschetti and Dowd,
1965). This paper describes 2 rat
leukaemias, one of a " myeloid " type and
the other of a " lymphoid " type, which
arose spontaneously in an August and
Hooded rat respectively. Syngeneic
transplants of these tumours may consti-
tute realistic models of human acute
leukaemias.
MATERIALS AND METHODS
Origins of the leukaemias.-The Sutton
August leukaemia (SAL) arose spontaneously
in 1966 in a normal female August rat and
has been maintained by serial transplantation
through syngeneic rats. In 1970 a stock of
frozen cells from a specific passage was laid
down in liquid nitrogen. The Hooded rat
leukaemia (HRL) arose in a normal male
Hooded rat in 1971. It has been maintained
by serial transplantation in Hooded rats, and
cells from the original donor rat have been
stored in liquid nitrogen.
Animals-Inbred August and Hooded
rats were obtained from the Chester Beatty
Research Institute breeding colonies.
Transplantation.-Blood obtained by
cardiac puncture from donors with a peri-
pheral white cell count of approximately
100,000 white cells/mm3 was heparinized,
then centrifuged at 500 g for 5 min and the
cells resuspended in tissue culture medium
199. Appropriate numbers of leukaemia
cells were injected into the sublingual vein of
anaesthetized rats in a volume of 0 5 ml.
Survival times were recorded following
intravenous inoculation of different numbers
of SAL and HRL cells into August and
Hooded rats respectively.
Pathological investigations.-These were
carried out on successive days on each of 2
August and Hooded rats following transplan-
tation of SAL and HRL cells. Blood
obtained by cardiac puncture was placed in
sequestrene tubes and white cell and platelet
counts were made with a Coulter electronic
(F) counter. The haemoglobin level was
determined by an oxyhaemoglobin method
(Dacie and Lewis, 1963). Peripheral blood
and bone marrow smears and imprints from
the spleen, lymph nodes and thymus were
fixed in methanol and stained in May-
Grrunwald Giemsa. The stained peripheral
blood and bone marrow smears were exam-
ined and differential counts calculated. The
leukaemic infiltration of the bone marrow
and tissue imprints were scored on a 1-5+
basis. Peripheral blood smears were stained
with Sudan black, Periodic Acid Schiff (PAS)GROWTH PATTERNS OF TRANSPLANTABLE LEUKAEMIAS
and for nonspecific esterase and acid phos-
phatase. Wet wYeights were recorded for the
liver and spleen and histological sections
were prepared from these and other organs.
The technique described by Delorme (1967)
with a few minor modifications, was used for
thoracic duct cannulation.
Lysis by murine anti-t serum and commple-
nment.-Leukaemia cells from the peripheral
blood wvere labelled for 30 min at 37°C with
5'Cr at a concentration of 200 yUCi/108 cells.
After washing, 2-5 x106 cells were added to
dilutions of 1/200-1/2000 antisera (obtained
from Searle) in a total volume 1 ml in Misco
microtest tubes and incubated for 30 min at
room temperature. The cells were then spun,
washed and resuspended in 1 ml rabbit
complement diluted 1/20 and incubated for a
further 30 min at 37°C on a rotary mixer
after wvhich they were spun and washedx 3.
The cell pellet and the wNashings were counted
separately in a y counter and lysis w!as
expressed as:
total count released inlto supernatant x 100
total count
RESULTS
Clinical course on transplantation into
syngeneic rats
SAL. After being inoculated with 104
SAL leukaemia cells, syngeneic rats died
8-10 days later although clinical symptoms
associated with anaemia and infection did
not manifest until one day before death.
Prominent features at autopsy were
splenomegaly and tissue pallor. The
peripheral lymph nodes were slightly
enlarged and the blood leucocytes at the
time of death ranged from 90 to 300,000/
mm3, ofwhich leukaemic blasts accounted
for 70-9000. The haemoglobin level was
reduced from the normal value of 13-15 g
to between 11-12 g/100 ml of blood and
the number of platelets fell from the
normal level of 800,000/mm3 to 100,000-
200,000/mm3. The cells in the bone
marrow were grossly abnormal and were
extensively replaced by leukaemic blast
cells.
HRL. During the early transplant
generations the usual duration of the
disease was 3-4 weeks. Clinical symp-
12
toms were apparent by the end of the
second week and included weakness,
ruffled fur, lymphadenopathy and pro-
gressive paralysis of the hind limbs.
With successive transplantation the
disease progressed more rapidly and the
rats remained ostensibly well until 48 h
before death. Hepatosplenomegaly and
lymphadenopathy were prominent fea-
tures at autopsy; the thymus was grossly
enlarged and large tumour masses sur-
rounded the spinal cord. Lung and liver
infiltration could be seen macroscopically
in the form ofperivascular tumour masses.
As the number of transplant generations
increased, and the average duration of the
disease decreased to 15-18 days, these
pathological observations became less
apparent. The peripheral blood count at
death varied between 500,000 and
1,000,000/mm3 in all transplant gener-
ations and more than 9500 of the cells
were leukaemic blasts. The haemo-
globin at death was in the range of 9-12 g/
100 ml blood and the platelet count was
50,000-80,000/mm3. Bone marrow infil-
tration was observed but occurred
later in the disease when compared with
the SAL, although at death the marrow
was almost totally replaced by lympho-
blasts.
Morphology and susceptibility to rinurine
anti-9 8erum
SAL. SAL leukaemia cells were
variable in size (15-30 ,m diameter) but
remarkably uniform for a myelogenous
leukaemia when compared with human
acute myeloid leukaemia. The cyto-
plasm was abundant, basophilic and
agranular. The nuclei were large,
irregular and often cleft with ill-defined
nucleoli. Electron micrographs of SAL
cells (Fig. 1) showed scanty nuclear
chromatin in clumps along the nuclear
membrane. The cytoplasm contained
abundant ribonucleoprotein particles,
spherical scattered mitochondria and
occasional channels of rough endoplasmic
reticulum. SAL cells stained with Sudan
black for lipid varied from negative to
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FIG. 1.-Electron micrograph of SAL cells. x 10,350.
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FIG. 2.-Electron micrograph of HRL cells. x 12,000.A. B. WRATHMELL
slightly positive. No PAS granules were
demonstrated and the majority of the
cells were negative for lysosomal enzymes
and acid phosphatases.
HRL.-HRL leukaemia cells ranged
in size from 0 to 20 ,tm. The large
nucleus was round, oval or slightly
indented with stippled rather coarse
chromatin and varying numbers of
nucleoli. The nuclear: cytoplasmic ratio
was high and in some cases the deeply
basophilic cytoplasm was visible only as a
narrow rim around the nucleus. Electron
micrographs (Fig. 2) showed scanty
nuclear chromatin with a tendency to
clump along the nuclear membrane.
Abundant ribonucleoprotein particles
were scattered through the cytoplasm.
There was little or no endoplasmic
reticulum and little sign of any Golgi
vesicles. Mitochondria varied in number
and tended to be oval or spherical.
HRL cells were Sudan black and PAS
negative.
The Table shows the % lysis of the
SAL and HRL cells after exposure to
murine anti-O serum, which is lytic for rat
thymocytes and rabbit complement.
HRL cells were lysed at dilutions of
1/2000 whereas SAL cells were essentially
unaffected by a 1/200 dilution.
Growth pattern
The growth ofHRL changed markedly
on transplantation and the growth of
leukaemia was therefore examined in an
early passage (P3) and a later passage
(P15). The growth of SAL which has
been transplanted for a number of years
TABLE-Lysis of SAL and HRL Cells
by Anti-O Sera and Complement 51Cr
Release Assay
% lysis at 90 min
Antiserum used HRL SAL
Anti-01:200+C' 78 10
Anti-0 1 : 2000 + C' 49 NT
Normal mouse serum 1: 100 + C' 13 10
C' alone 6 7
NT, not tested.
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FIG. 3.-The effect of cell dose on the
survival times of August rats inoculated
with SAL and Hoodedrats inoculated with
HRL passage 3 and passage 15. Each
point represents the mean survival of at
least 3 animals.
and has shown no variation in growth
characteristics, was examined in passage
20. The relationship between the number
of SAL cells injected into August rats and
HRL cells into Hooded rats and the
length of survival is shown in Fig. 3,
which illustrates the differences in the
time courses ofthe 2 diseases and also the
change in growth pattern of the HRL
leukaemia on prolonged transplantation.
After passage 15 the HRL did not undergo
further changes and 14-18 days remained
the average survival time ofrats following
an injection of 106 cells. Changes in the
white cell count, platelet count, haemo-
globin values, percentage of blasts and
degree of involvement of the spleen,
lymph nodes and bone marrow are shown
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Blasts
Lymph I glands 1 2
1 2 3 4 5 6 7 8
Days
104 cells IV
FiG. 4.-The growth pattern of SAL (passage 20) following inoculation into August rats (see text).
Hb, haemoglobin. WBC, Total white cell count.
in Fig. 4 for SAL and in Fig. 5 and 6 for
HRL at 2 different passages.
SAL cells proliferated initially mainly
in the bone marrow. At 4-6 days blasts
could be detected in the spleen and
peripheral blood and on subsequent days
the peripheral blood white cell count
started to rise, with a concomitant increase
in the blast count. There was a total
increase of only 1 g in the wet weight of
the liver but 1-1.5 g increase in the
spleen representing a three-fold increase
over the initial value: the increase in
weight in both cases took place from Days
6-8. By Day 7-8 other organs became
involved and in addition to extensive
infiltration of the red pulp of the spleen
some leukaemic blasts could be seen in the
thymus and in the sinusoids of the lymph
nodes, suggesting that there was no true
colonization of these organs. This was
supported by the observation that when
the peripheral blood count was 90-
300,000/mm3 only a small percentage of
blasts could be found in the thoracic duct
lymph. Liver involvement was confined
to the sinusoids and a few leukaemic
blasts could be seen in the glomerular
medullary capillaries of the kidney and
alveolar capillaries of the lung.
The early passages of the HRL
contrasted with the SAL in that leukaemia
cells proliferated initially in the spleen and
not the bone marrow. Blasts became
detectable in the peripheral blood at Day
7, after which there was a sharp increase
up to 14-16 days when a final plateaut was
reached. Blasts became identifiable in
the lymph nodes and bone marrow at
9-10 days and the number of platelets
began to increase at 12-14 days. Spleen
weight remained constant until Day 8,
then increased rapidly until a value of 6
times the normal value was reached.
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FIG. 5. The growth pattern of HRL (passage 3) following inoculation into Hoodledl rats (see text).
The liver showed only a 1% increase in
weight during the same period. The
growth of HRL cells in Hooded rats in
later passages (from passage 8-9) showed a
striking change. Survival time was de-
creased by about 7 days. Leukaemic
cells proliferated in the bone marrow and
not the spleen; blasts become detectable
at 5 days and at the same time being
identified in the peripheral blood. Here
the number of blasts rose slowly until the
eighth day when it increased very rapidly
so that during the next few days blasts
accounted for nearly all the white cells in
the blood. As the HRL blasts began to
accumulate rapidly in the peripheral
blood they became detectable in the
spleen where invasion was rapid and
caused a seven-fold increase in spleen
weight. Lymph node involvement was a
comparatively late event and not very
extensive. In the later passages blasts in
the lymph nodes first became detectable
between 10 and 12 days. In contrast to
the SAL 40%0 leukaemic blasts could be
detected in the thoracic duct of Hooded
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FiG. 6. The growth pattern of HRL (passage 15) following inoculation ilnto
comparison with Fig. 5).
Hoo(ledl rats (for
rats cannulated when the peripheral
blood count was 100,000/mm3. The level
of blasts in the thoracic duct was similar
in all transplant generations. Involve-
ment of most organs occurred and was
similar in pattern in all passages but was
less extensive in the later ones. The
normal architecture of the spleen, lymph
nodes and thymus was destroyed and
tumour masses could be seen in the liver
surrounding the periportal tracts and in
the sinusoids, as well as in the medullary
and glomerular capillaries of the kidney
and in the peribronchial and perivascular
areas of the lung. In early passages
involvement of the CNS was extensive;
the spinal cord, brain, peripheral nerves
and the musculature
vertebral column were
tumour cells.
surrouniding the
all infiltrated by
DISCUSSION
SAL and HRL leukaemias cannot be
clearly classified by morphological criteria
alone, but functionally SAL can be
considered to be a " myeloid" leukaemia
because (1) bone marrow colonization
occurs early in the disease with lymphoid
involvement being apparently of a
secondary nature; (2) the lymph nodes
themselves were not extensively infiltrated
and the lymphoid follicles remained
intact; (3) the spleen, although heavily
involved, showed proliferation primarily
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in the red pulp and not in the Malpighian
corpuscles; (4) even when a high percent-
age ofblasts were present in the peripheral
blood very few of these could be detected
in the thoracic duct lymph; (5) the cells
were not lysed by a murine anti-O serum.
The lymphoid character of the HRL
leukaemia is indicated (1) by extensive
involvement especially in early transplant
generations of lymphoid organs, including
the thymus; (2) destruction of the
lymphoid follicles in the lymph nodes;
(3) invasion of the white pulp of the
spleen; (4) the presence ofhigh numbers of
blasts in the thoracic duct lymph; (5)
susceptibility to lysis by murine anti-O
serum and complement. In early trans-
plant generations bone marrow colon-
ization was a late event but occurred
progressively earlier with subsequent
transplantation and in this respect the
pattern of growth of the HRL became
more like that of SAL.
Both diseases are acute in nature and
are in several respects comparable to
acute myeloblastic leukaemia (AML) and
acute lymphoblastic leukaemia (ALL) in
man.
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